RP-901

1. Evaluate the pharmacokinetic characteristics and safety of RP901 and its metabolites dibutyrylglucosamine and butyrylglucosamine in healthy Chinese adult subjects under fasting and postprandial administration conditions, and provide basis and information for later clinical trials 2. Study the safety, tolerability and pharmacokinetic characteristics of multiple oral administration of RP901 tablets in healthy Chinese adult subjects, and compare the pharmacokinetics after single and multiple administrations, and provide basis and information for later clinical trials

To study the safety, tolerability and pharmacokinetic characteristics of a single oral administration of different doses of RP901 tablets to healthy adult Chinese volunteers, and to provide basis and information for later clinical trials